← Open Payments lookup

DALE NELSON: Open Payments

NPI 1376856385 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,807 in 101 payments from 21 companies in 2025. Trend: 2023 $1,239 · 2024 $2,177 · 2025 $1,807

Food & beverage: $1,807
CompanyPaymentsAmount
Novo Nordisk Inc16$344
ABBVIE INC.25$269
PFIZER INC.15$207
Corcept Therapeutics8$199
AstraZeneca Pharmaceuticals LP7$150
GlaxoSmithKline, LLC.5$113
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$76
Lilly USA, LLC3$73
Collegium Pharmaceutical, Inc.3$53

Products named: Ozempic, Korlym, PREVNAR 20, SHINGRIX, VRAYLAR, CAPLYTA, UBRELVY, QULIPTA.

Industry payments across WA — which companies pay providers there.